BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2536062)

  • 1. Signaling through T lymphocyte surface proteins, TCR/CD3 and CD28, activates the HIV-1 long terminal repeat.
    Tong-Starkesen SE; Luciw PA; Peterlin BM
    J Immunol; 1989 Jan; 142(2):702-7. PubMed ID: 2536062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-mitogenic T cell activation signals are sufficient for induction of human immunodeficiency virus transcription.
    Gruters RA; Otto SA; Al BJ; Verhoeven AJ; Verweij CL; Van Lier RA; Miedema F
    Eur J Immunol; 1991 Jan; 21(1):167-72. PubMed ID: 1846814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes.
    Turka LA; Ledbetter JA; Lee K; June CH; Thompson CB
    J Immunol; 1990 Mar; 144(5):1646-53. PubMed ID: 2155264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD28-induced T cell activation. Evidence for a protein-tyrosine kinase signal transduction pathway.
    Lu Y; Granelli-Piperno A; Bjorndahl JM; Phillips CA; Trevillyan JM
    J Immunol; 1992 Jul; 149(1):24-9. PubMed ID: 1318900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for the involvement of three distinct signals in the induction of IL-2 gene expression in human T lymphocytes.
    June CH; Ledbetter JA; Lindsten T; Thompson CB
    J Immunol; 1989 Jul; 143(1):153-61. PubMed ID: 2543699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling requirements for the expression of the transactivating factor NF-AT in human T lymphocytes.
    Hivroz-Burgaud C; Clipstone NA; Cantrell DA
    Eur J Immunol; 1991 Nov; 21(11):2811-9. PubMed ID: 1682154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporin A inhibits the early phase of NF-kappaB/RelA activation induced by CD28 costimulatory signaling to reduce the IL-2 expression in human peripheral T cells.
    Nishiyama S; Manabe N; Kubota Y; Ohnishi H; Kitanaka A; Tokuda M; Taminato T; Ishida T; Takahara J; Tanaka T
    Int Immunopharmacol; 2005 Apr; 5(4):699-710. PubMed ID: 15710339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple signals are required for function of the human granulocyte-macrophage colony-stimulating factor gene promoter in T cells.
    Jenkins F; Cockerill PN; Bohmann D; Shannon MF
    J Immunol; 1995 Aug; 155(3):1240-51. PubMed ID: 7636192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear import of HIV-1 DNA in resting CD4+ T cells requires a cyclosporin A-sensitive pathway.
    Sun Y; Pinchuk LM; Agy MB; Clark EA
    J Immunol; 1997 Jan; 158(1):512-7. PubMed ID: 8977229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of primary human T-lymphocytes through CD2 plus CD28 adhesion molecules induces long-term nuclear expression of NF-kappa B.
    Costello R; Lipcey C; Algarté M; Cerdan C; Baeuerle PA; Olive D; Imbert J
    Cell Growth Differ; 1993 Apr; 4(4):329-39. PubMed ID: 8098618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD28-stimulated IL-2 gene expression in Jurkat T cells occurs in part transcriptionally and is cyclosporine-A sensitive.
    Williams TM; Moolten DM; Makni H; Kim HW; Kant JA; Kamoun M
    J Immunol; 1992 Apr; 148(8):2609-16. PubMed ID: 1348520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of NF-kappa B1 (p50/p105) gene expression in activation of human blood T-lymphocytes via CD2 and CD28 adhesion molecules.
    Costello R; Cerdan C; Lipcey C; Algarté M; Martin Y; Baeuerle PA; Olive D; Imbert J
    Cell Growth Differ; 1993 Nov; 4(11):947-54. PubMed ID: 7905283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetraspanin CD81 provides a costimulatory signal resulting in increased human immunodeficiency virus type 1 gene expression in primary CD4+ T lymphocytes through NF-kappaB, NFAT, and AP-1 transduction pathways.
    Tardif MR; Tremblay MJ
    J Virol; 2005 Apr; 79(7):4316-28. PubMed ID: 15767432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functionally anergic lpr and gld B220+ T cell receptor (TCR)-alpha/beta+ double-negative T cells express CD28 and respond to costimulation with phorbol myristate acetate and antibodies to CD28 and the TCR.
    Giese T; Allison JP; Davidson WF
    J Immunol; 1993 Jul; 151(2):597-609. PubMed ID: 7687618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of nuclear factor-kappa B and activator protein-1 activities after stimulation of T cells via glycosylphosphatidylinositol-anchored Ly-6A/E.
    Ivanov V; Fleming TJ; Malek TR
    J Immunol; 1994 Sep; 153(6):2394-406. PubMed ID: 7915738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiologic activation of T cells via the T cell receptor induces NF-kappa B.
    Jamieson C; McCaffrey PG; Rao A; Sen R
    J Immunol; 1991 Jul; 147(2):416-20. PubMed ID: 1830061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A protein kinase C-activating phorbol ester accelerates the T cell antigen receptor-stimulated phosphatidylinositol cycle in normal human CD4+ T cells.
    Whelan JP; Shearer WT; Gilliam EB; Hardy KJ
    J Immunol; 1992 May; 148(9):2872-8. PubMed ID: 1349321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell receptor/CD3 and CD28 use distinct intracellular signaling pathways.
    Van Lier RA; Brouwer M; De Groot ED; Kramer I; Aarden LA; Verhoeven AJ
    Eur J Immunol; 1991 Jul; 21(7):1775-8. PubMed ID: 1647959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced susceptibility to HIV-1 infection of ethyl-methanesulfonate-treated CEM subclones correlates with a blockade in their protein kinase C signaling pathway.
    Hillman K; Qian J; Siegel JN; Roderiquez G; Blackburn R; Manischewitz J; Norcross M; Golding H
    J Immunol; 1992 Jun; 148(12):3991-8. PubMed ID: 1351090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ET-18-OCH3 inhibits nuclear factor-kappa B activation by 12-O-tetradecanoylphorbol-13-acetate but not by tumor necrosis factor-alpha or interleukin 1 alpha.
    Daniel LW; Civoli F; Rogers MA; Smitherman PK; Raju PA; Roederer M
    Cancer Res; 1995 Nov; 55(21):4844-9. PubMed ID: 7585518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.